Biocon Unveils Rs 11,450 Crore Capital Plan For Biologics Integration 0 06.12.2025 11:13 Ndtv.com The preferential issue will involve 17.12 crore equity shares of Biocon at a price determined under SEBI norms, aggregating up to Rs 6,950 crore. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
